Journal article
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010
The Lancet (British edition), Vol.380(9859), pp.2095-2128
12/15/2012
DOI: 10.1016/S0140-6736(12)61728-0
PMCID: PMC10790329
PMID: 23245604
Abstract
Background Reliable and timely information on the leading causes of death in populations, and how these are changing, is a crucial input into health policy debates. In the Global Burden of Diseases, Injuries, and Risk Factors Study 2010 (GBD 2010), we aimed to estimate annual deaths for the world and 21 regions between 1980 and 2010 for 235 causes, with uncertainty intervals (UIs), separately by age and sex.
Methods We attempted to identify all available data on causes of death for 187 countries from 1980 to 2010 from vital registration, verbal autopsy, mortality surveillance, censuses, surveys, hospitals, police records, and mortuaries. We assessed data quality for completeness, diagnostic accuracy, missing data, stochastic variations, and probable causes of death. We applied six different modelling strategies to estimate cause-specific mortality trends depending on the strength of the data. For 133 causes and three special aggregates we used the Cause of Death Ensemble model (CODEm) approach, which uses four families of statistical models testing a large set of different models using different permutations of covariates. Model ensembles were developed from these component models. We assessed model performance with rigorous out-of-sample testing of prediction error and the validity of 95% UIs. For 13 causes with low observed numbers of deaths, we developed negative binomial models with plausible covariates. For 27 causes for which death is rare, we modelled the higher level cause in the cause hierarchy of the GBD 2010 and then allocated deaths across component causes proportionately, estimated from all available data in the database. For selected causes (African trypanosomiasis, congenital syphilis, whooping cough, measles, typhoid and parathyroid, leishmaniasis, acute hepatitis E, and HIV/AIDS), we used natural history models based on information on incidence, prevalence, and case-fatality. We separately estimated cause fractions by aetiology for diarrhoea, lower respiratory infections, and meningitis, as well as disaggregations by subcause for chronic kidney disease, maternal disorders, cirrhosis, and liver cancer. For deaths due to collective violence and natural disasters, we used mortality shock regressions. For every cause, we estimated 95% UIs that captured both parameter estimation uncertainty and uncertainty due to model specification where CODEm was used. We constrained cause-specific fractions within every age-sex group to sum to total mortality based on draws from the uncertainty distributions.
Findings In 2010, there were 52.8 million deaths globally. At the most aggregate level, communicable, maternal, neonatal, and nutritional causes were 24.9% of deaths worldwide in 2010, down from 15.9 million (34.1%) of 46.5 million in 1990. This decrease was largely due to decreases in mortality from diarrhoeal disease (from 2.5 to 1.4 million), lower respiratory infections (from 3.4 to 2.8 million), neonatal disorders (from 3.1 to 2.2 million), measles (from 0.63 to 0.13 million), and tetanus (from 0.27 to 0.06 million). Deaths from HIV/AIDS increased from 0.30 million in 1990 to 1.5 million in 2010, reaching a peak of 1.7 million in 2006. Malaria mortality also rose by an estimated 19.9% since 1990 to 1.17 million deaths in 2010. Tuberculosis killed 1.2 million people in 2010. Deaths from non-communicable diseases rose by just under 8 million between 1990 and 2010, accounting for two of every three deaths (34.5 million) worldwide by 2010. 8 million people died from cancer in 2010, 38% more than two decades ago; of these, 1.5 million (19%) were from trachea, bronchus, and lung cancer. Ischaemic heart disease and stroke collectively killed 12.9 million people in 2010, or one in four deaths worldwide, compared with one in five in 1990; 1.3 million deaths were due to diabetes, twice as many as in 1990. The fraction of global deaths due to injuries (5.1 million deaths) was marginally higher in 2010 (9.6%) compared with two decades earlier (8.8%). This was driven by a 46% rise in deaths worldwide due to road traffic accidents (1.3 million in 2010) and a rise in deaths from falls. Ischaemic heart disease, stroke, chronic obstructive pulmonary disease (COPD), lower respiratory infections, lung cancer, and HIV/AIDS were the leading causes of death in 2010. Ischaemic heart disease, lower respiratory infections, stroke, diarrhoeal disease, malaria, and HIV/AIDS were the leading causes of years of life lost due to premature mortality (YLLs) in 2010, similar to what was estimated for 1990, except for HIV/AIDS and preterm birth complications. YLLs from lower respiratory infections and diarrhoea decreased by 45-54% since 1990; ischaemic heart disease and stroke YLLs increased by 17-28%. Regional variations in leading causes of death were substantial. Communicable, maternal, neonatal, and nutritional causes still accounted for 76% of premature mortality in sub-Saharan Africa in 2010. Age standardised death rates from some key disorders rose (HIV/AIDS, Alzheimer's disease, diabetes mellitus, and chronic kidney disease in particular), but for most diseases, death rates fell in the past two decades; including major vascular diseases, COPD, most forms of cancer, liver cirrhosis, and maternal disorders. For other conditions, notably malaria, prostate cancer, and injuries, little change was noted.
Interpretation Population growth, increased average age of the world's population, and largely decreasing age-specific, sex-specific, and cause-specific death rates combine to drive a broad shift from communicable, maternal, neonatal, and nutritional causes towards non-communicable diseases. Nevertheless, communicable, maternal, neonatal, and nutritional causes remain the dominant causes of YLLs in sub-Saharan Africa. Overlaid on this general pattern of the epidemiological transition, marked regional variation exists in many causes, such as interpersonal violence, suicide, liver cancer, diabetes, cirrhosis, Chagas disease, African trypanosomiasis, melanoma, and others. Regional heterogeneity highlights the importance of sound epidemiological assessments of the causes of death on a regular basis.
Details
- Title: Subtitle
- Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010
- Creators
- Rafael Lozano - Institute for Health Metrics and EvaluationMohsen Naghavi - Institute for Health Metrics and EvaluationKyle Foreman - Imperial College LondonStephen Lim - Institute for Health Metrics and EvaluationKenji Shibuya - University of Tokyo Health SciencesVictor Aboyans - Dupuytren Univ Hosp, Dept Cardiol, Limoges, FranceJerry Abraham - The University of Texas at San AntonioTimothy Adair - The University of QueenslandRakesh Aggarwal - Sanjay Gandhi Post Graduate Institute of Medical SciencesStephanie Y. Ahn - Institute for Health Metrics and EvaluationMiriam Alvarado - Institute for Health Metrics and EvaluationH. Ross Anderson - St George's, University of LondonLaurie M. Anderson - Public Health – Seattle & King CountyKathryn G. Andrews - Institute for Health Metrics and EvaluationCharles Atkinson - Institute for Health Metrics and EvaluationLarry M. Baddour - Mayo Clinic in ArizonaSuzanne Barker-Collo - University of AucklandDavid H. Bartels - Harvard UniversityMichelle L. Bell - Yale UniversityEmelia J. Benjamin - Boston UniversityDerrick Bennett - University of OxfordKavi Bhalla - Harvard UniversityBoris Bikbov - V.I.Shumakov Federal Research Center of Transplantology and Artificial OrgansAref Bin Abdulhak - King Fahd Medical CityGretchen Birbeck - Michigan State UniversityFiona Blyth - The University of SydneyIan Bolliger - Institute for Health Metrics and EvaluationSoufi Ane BoufousChiara Bucello - UNSW SydneyMichael Burch - University College LondonPeter Burney - Imperial College LondonJonathan Carapetis - The Kids Research Institute AustraliaHonglei Chen - National Institute of Environmental Health SciencesDavid Chou - Institute for Health Metrics and EvaluationSumeet S. Chugh - Cedars-Sinai Medical CenterLuc E. Coffeng - Erasmus MCSteven D. Colan - Harvard UniversitySamantha Colquhoun - Menzies School of Health ResearchK. Ellicott Colson - Institute for Health Metrics and EvaluationJohn Condon - Menzies School of Health ResearchMyles D. Connor - National Health Service ScotlandLeslie T. Cooper - Loyola University ChicagoMatthew Corriere - Wake Forest UniversityMonica Cortinovis - Mario Negri Institute for Pharmacological ResearchKaren Courville de Vaccaro - Hosp Dr Gustavo N Collado, Puerto Chitre, PanamaWilliam Couser - University of WashingtonBenjamin C. Cowie - Victorian Infectious Diseases Reference LaboratoryMichael H. Criqui - University of California San DiegoMarita Cross - The University of SydneyKaustubh C. Dabhadkar - Emory UniversityNabila Dahodwala - University of PennsylvaniaDiego De Leo - Griffith UniversityLouisa Degenhardt - Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW, AustraliaAllyne Delossantos - Institute for Health Metrics and EvaluationJulie Denenberg - University of California San DiegoDon C. Des Jarlais - Beth Israel Deaconess Med Ctr, New York, NY 10003 USASamath D. Dharmaratne - University of PeradeniyaE. Ray Dorsey - Johns Hopkins UniversityTim Driscoll - The University of SydneyHerbert Duber - University of WashingtonBeth Ebel - University of WashingtonPatricia J. Erwin - Mayo Clinic in ArizonaPatricia Espindola - Hospital MacielMajid Ezzati - University of LondonValery Feigin - Auckland University of TechnologyAbraham D. Flaxman - Institute for Health Metrics and EvaluationMohammad H. Forouzanfar - Institute for Health Metrics and EvaluationFrancis Gerry R. Fowkes - University of EdinburghRichard Franklin - James Cook UniversityMarlene Fransen - The University of SydneyMichael K. Freeman - Institute for Health Metrics and EvaluationSherine E. Gabriel - Mayo Clinic in ArizonaEmmanuela Gakidou - Institute for Health Metrics and EvaluationFlavio Gaspari - Mario Negri Institute for Pharmacological ResearchRichard F. Gillum - Howard UniversityDiego Gonzalez-Medina - Institute for Health Metrics and EvaluationYara A. Halasa - Brandeis UniversityDiana Haring - Institute for Health Metrics and EvaluationJames E. Harrison - Flinders UniversityRasmus Havmoeller - Karolinska University HospitalRoderick J. Hay - King's College HospitalBruno Hoen - Université de franche-comtéPeter J. Hotez - Baylor College of MedicineDamian Hoy - Monash UniversityKathryn H. Jacobsen - George Mason UniversitySpencer L. James - Institute for Health Metrics and EvaluationRashmi Jasrasaria - Institute for Health Metrics and EvaluationSudha Jayaraman - Brigham and Women's HospitalNicole Johns - Institute for Health Metrics and EvaluationGanesan Karthikeyan - All India Institute of Medical SciencesNicholas Kassebaum - University of WashingtonAndre Keren - Hebrew University of JerusalemJon-Paul Khoo - The University of QueenslandLisa Marie Knowlton - Dana-Farber/Harvard Cancer CenterOlive Kobusingye - University of South AfricaAdofo Koranteng - Kwame Nkrumah University of Science and TechnologyRita Krishnamurthi - Auckland University of TechnologyMichael Lipnick - University of California, San FranciscoSteven E. Lipshultz - University of MiamiSummer Lockett Ohno - Institute for Health Metrics and EvaluationDavid C Schwebel (Contributor) - Research AdministrationGlobal Burden of Disease Study 2010 Collaborators
- Resource Type
- Journal article
- Publication Details
- The Lancet (British edition), Vol.380(9859), pp.2095-2128
- DOI
- 10.1016/S0140-6736(12)61728-0
- PMID
- 23245604
- PMCID
- PMC10790329
- NLM abbreviation
- Lancet
- ISSN
- 0140-6736
- eISSN
- 1474-547X
- Publisher
- Elsevier
- Number of pages
- 34
- Grant note
- K23 AG034236 / NIH; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA Parkinson Council NIH; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA WHO; World Health Organization Commonwealth Government of Australia; Australian Government CONCAWE (Conservation of Clean Air and Water Europe) Dana Foundation Hospital de Cruces Rheumatology Association Dutch Government Bill & Melinda Gates Foundation through the Sabin Institute
- Language
- English
- Date published
- 12/15/2012
- Academic Unit
- Research Administration
- Record Identifier
- 9984949191502771
Metrics
6 Record Views